File Download
 
 
Patent History
  • Application
    US 12/866118 2009-02-04
  • Publication
    US 20110009369 2011-01-13
 
Supplementary

Published Patent: ANTI-INFLUENZA COMPOUNDS
  • Basic View
  • Metadata View
  • XML View
TitleANTI-INFLUENZA COMPOUNDS
 
Priority Date2009-02-04 US 12/866118
2008-02-05 US 12/026167P
2009-02-04 PCT/CA2009000133
 
InventorsJones, S
Lau, ASY
An, JH
Law, HY
Lee, DCW
Poon, LLM
 
Issue Date2009
 
CitationUS Published patent application US 20110009369. Washington, DC: US Patent and Trademark Office (USPTO), 2011 [How to Cite?]
 
AbstractThe present invention provides pyrimidinyl compounds of formula (I) and pharmaceutically acceptable salts thereof. These compounds may be used for the inhibition of influenza. In particular, the compounds of the invention may be used for the treatment or prophylaxis of influenza A, most particularly H1N1 or H5N1 influenza. The compounds of the invention can also be used for the treatment or prophylaxis of a disease caused by Vibrio cholerae, Clostridium perfringens, Streptococcus pneumoniae, Arthrobacter sialophilus, an orthomyxovirus, a paramyxovirus, a parainfluenza virus, mumps virus, Newcastle disease virus, fowl plague virus or Sendai virus.
 
DC FieldValue
dc.contributor.inventorJones, S
 
dc.contributor.inventorLau, ASY
 
dc.contributor.inventorAn, JH
 
dc.contributor.inventorLaw, HY
 
dc.contributor.inventorLee, DCW
 
dc.contributor.inventorPoon, LLM
 
dc.date.accessioned2010-07-13T04:01:35Z
 
patents.date.application2009-02-04
 
dc.date.available2010-07-13T04:01:35Z
 
dc.date.issued2009
 
patents.date.priority2009-02-04 US 12/866118
 
patents.date.priority2008-02-05 US 12/026167P
 
patents.date.priority2009-02-04 PCT/CA2009000133
 
patents.date.publication2011-01-13
 
dc.description.abstractThe present invention provides pyrimidinyl compounds of formula (I) and pharmaceutically acceptable salts thereof. These compounds may be used for the inhibition of influenza. In particular, the compounds of the invention may be used for the treatment or prophylaxis of influenza A, most particularly H1N1 or H5N1 influenza. The compounds of the invention can also be used for the treatment or prophylaxis of a disease caused by Vibrio cholerae, Clostridium perfringens, Streptococcus pneumoniae, Arthrobacter sialophilus, an orthomyxovirus, a paramyxovirus, a parainfluenza virus, mumps virus, Newcastle disease virus, fowl plague virus or Sendai virus.
 
patents.description.assigneeBRITISH COLUMBIA CANCER AGENCY BRANCH [CA]
 
patents.description.ccUS
 
patents.description.countryUnited States of America
 
patents.description.kindA1
 
dc.description.naturepublished_or_final_version
 
patents.identifier.applicationUS 12/866118
 
dc.identifier.citationUS Published patent application US 20110009369. Washington, DC: US Patent and Trademark Office (USPTO), 2011 [How to Cite?]
 
dc.identifier.hkuros161136
 
patents.identifier.publicationUS 20110009369
 
dc.identifier.urihttp://hdl.handle.net/10722/62454
 
dc.languageeng
 
patents.relation.familyCA 2713848 (A1) 2009-08-13
 
patents.relation.familyWO 2009097682 (A1) 2009-08-13
 
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documents
 
dc.titleANTI-INFLUENZA COMPOUNDS
 
dc.typePatent
 
patents.typePatent_published
 
<?xml encoding="utf-8" version="1.0"?>
<item><date.accessioned>2010-07-13T04:01:35Z</date.accessioned>
<date.available>2010-07-13T04:01:35Z</date.available>
<date.issued>2009</date.issued>
<identifier.citation>US Published patent application US 20110009369. Washington, DC: US Patent and Trademark Office (USPTO), 2011</identifier.citation>
<identifier.uri>http://hdl.handle.net/10722/62454</identifier.uri>
<description.abstract>The present invention provides pyrimidinyl compounds of formula (I) and pharmaceutically acceptable salts thereof. These compounds may be used for the inhibition of influenza. In particular, the compounds of the invention may be used for the treatment or prophylaxis of influenza A, most particularly H1N1 or H5N1 influenza. The compounds of the invention can also be used for the treatment or prophylaxis of a disease caused by Vibrio cholerae, Clostridium perfringens, Streptococcus pneumoniae, Arthrobacter sialophilus, an orthomyxovirus, a paramyxovirus, a parainfluenza virus, mumps virus, Newcastle disease virus, fowl plague virus or Sendai virus.</description.abstract>
<language>eng</language>
<rights>Creative Commons: Attribution 3.0 Hong Kong License For Public Patent Documents</rights>
<title>ANTI-INFLUENZA COMPOUNDS</title>
<type>Patent</type>
<description.nature>published_or_final_version</description.nature>
<identifier.hkuros>161136</identifier.hkuros>
<contributor.inventor>Jones, S</contributor.inventor>
<contributor.inventor>Lau, ASY</contributor.inventor>
<contributor.inventor>An, JH</contributor.inventor>
<contributor.inventor>Law, HY</contributor.inventor>
<contributor.inventor>Lee, DCW</contributor.inventor>
<contributor.inventor>Poon, LLM</contributor.inventor>
<patents.identifier.application>US 12/866118</patents.identifier.application>
<patents.description.assignee>BRITISH COLUMBIA CANCER AGENCY BRANCH [CA]</patents.description.assignee>
<patents.description.country>United States of America</patents.description.country>
<patents.date.publication>2011-01-13</patents.date.publication>
<patents.date.application>2009-02-04</patents.date.application>
<patents.date.priority>2009-02-04 US 12/866118</patents.date.priority>
<patents.date.priority>2008-02-05 US 12/026167P</patents.date.priority>
<patents.date.priority>2009-02-04 PCT/CA2009000133</patents.date.priority>
<patents.description.cc>US</patents.description.cc>
<patents.identifier.publication>US 20110009369</patents.identifier.publication>
<patents.relation.family>CA 2713848 (A1)  2009-08-13</patents.relation.family>
<patents.relation.family>WO 2009097682 (A1)  2009-08-13</patents.relation.family>
<patents.description.kind>A1</patents.description.kind>
<patents.type>Patent_published</patents.type>
<bitstream.url>http://hub.hku.hk/bitstream/10722/62454/1/US2011009369A1.pdf</bitstream.url>
</item>